Navigation Links
Lilly Receives NCQA Health Information Product Certification for Interactive Online Health Education Answers Program

INDIANAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- Lilly's (NYSE: LLY) Health Education Answers, an interactive online program, has received Health Information Product Certification from the National Committee for Quality Assurance (NCQA) for the Health Risk Appraisals and Interactive Consumer Health Tools certification options. NCQA is a private, non-profit organization dedicated to providing health care quality information through the Web and the media in order to help consumers, employers, and others make more informed health care choices.

"Earning NCQA's Health Information Product Certification demonstrates that an organization has expertise in gathering and disseminating health care information for patients," said Kathleen C. Mudd, vice president, Product Delivery, NCQA. "Lilly is to be commended for being the first pharmaceutical company in the nation to be reviewed for these services."

Health Education Answers is a Web-based program designed for managed care and public payer organizations to assist in further driving the standard of patient care through interactive educational information. Patients accessing the program can progress through an entire neighborhood of health education and disease management modules, including: ADHD, Bipolar Disorder, Depression, Diabetes, Diabetes Complications, Manage Your Weight, Medication Safety, Men's Health, Schizophrenia, Smoking & Addictions, and Women's Health.

Available in English and Spanish with full audio, the Health Education Answers program includes research-supported patient education material that adheres to national clinical guidelines. This tool educates patients on several health areas, including proper diet and exercise, healthy habits to teach their kids, and simple steps to help themselves and their families prevent illness.

Health Education Answers also includes an optional health risk assessment that helps patients identify and understand their individual health needs and at-risk behaviors and suggestions for improvement. Based on the results, Health Education Answers then directs patients to the most applicable education modules.

"The Health Education Answers program is another example of Lilly's commitment to going beyond medicine to support the overall health needs of patients," said Jack Bailey, vice president, Lilly. "Receiving HIP certification is especially important to us because it is an external validation from an independent team of health care professionals that this intervention meets rigorous quality standards."

Programs such as Health Education Answers improve health and wellness while reducing health care costs for payers and their patients. According to a report released by the Trust for America's Health, researchers indicate that preventive measures will reduce the cost of health care, estimating that for an annual investment of $10 in a "proven" community prevention program, the return on investment in 10 to 20 years will exceed $6 for every dollar invested.(i)

Lilly also offers three Disease Management programs with NCQA Program Design Certification as part of its ongoing commitment to improving the standard of patient care. They include:

-- Tools That Empower(TM) Depression Care Management Program -- A program designed for managed care organizations to assist in further driving the standard of patient care around Major Depressive Disorder.

-- Tools That Empower(TM) Diabetes Management Program -- A robust diabetes disease management program that contains more than 20 best-in-class tools and resources for care managers and diabetes program directors.

-- HealthInsights for Women -- A disease management program designed for women aged 30 years and older that provides information about disease risk factors and encourages them to make behavior changes that can lead to better health.

For more information about Lilly's disease management and health education programs, visit and

About NCQA:

NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA is committed to providing health care quality information through the Web and the media in order to help consumers, employers and others make more informed health care choices.

Consumers can access an organization's NCQA Accreditation and Certification status and other information on health care quality on NCQA's Web site at, or by calling NCQA Customer Support at (888) 275-7585.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at


(i) Trust for America's Health, Blueprint for a Healthier America: Modernizing The Federal Public Health System To Focus On Prevention And Preparedness, Washington, DC: Trust for America's Health, October 2008. (accessed Nov. 4, 2008).

(Logo: )

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
(Date:11/24/2015)... ... 2015 , ... With Thanksgiving right around the corner, holiday travel season is ... your family and vehicle. , According to the National Highway Traffic Safety Administration, 301 ... sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... Abington Hospital – Jefferson Health ... Quality® Bariatric Surgery Facility for treating individuals living with morbid or extreme obesity. ... available to its members to help them make informed decisions about their healthcare ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir Grout of Baltimore ... TrustDale certification. The award recognizes good companies for excellence in service and a ... grout, and hard surface restoration company earned this recognition after a thorough review ...
(Date:11/24/2015)... ... 24, 2015 , ... Autism Speaks, the world’s leading autism science and advocacy ... and the generosity of people around the world. On December 1, supporters can make ... – and share the personal stories behind those gifts. , Just as Black ...
(Date:11/24/2015)... ... , ... All her life, Don Peck’s mother wondered if she was a descendant of Samuel ... After a 25-year search for information, Don and his aunt discovered that she was ... Turns out, it was Don’s father who was descended from not one, but four ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Thanks to a donor ... St. Mary,s Medical Center,s Sister Diane Grassilli Center for ... capabilities in San Francisco . ... friend, stepped forward with a gift of $617,320 that ... Digital Mammography with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, ...
(Date:11/24/2015)... 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the ... that the first patient has been enrolled in ESSA,s ... for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States and ... clinical trial, ESSA intends to demonstrate the safety, tolerability, ...
(Date:11/24/2015)... --> --> ... by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich ... Lumbar Interbody Fusion), End User, and Geography - Global Forecast ... at $1.90 Billion in 2014 and is expected to reach ... the forecast period of 2015 to 2020. Browse ...
Breaking Medicine Technology: